Fibroscan cap measurement
GENFIT
Genfit S.A. (the “Company”) previously disclosed in a Form 6-K furnished with the Securities and Exchange Commission (the “SEC”) on April 29, 2020 that it was delaying the filing of this Annual Report on Form 20-F for the year ended December 31, 2019 in reliance on the order issued by the SEC on March 4, 2020 in SEC Release No. 34-88318, as extended and amended on March 25, 2020 in SEC ...
[DOCX File]Veterans Affairs
https://info.5y1.org/fibroscan-cap-measurement_1_90585f.html
PAGE 1 OF1. REQUISITION NO. 2. CONTRACT NO.3. AWARD/EFFECTIVE DATE4. ORDER NO.5. SOLICITATION NUMBER6. SOLICITATION ISSUE DATEa. NAMEb. TELEPHONE NO. (No Collect ...
[DOC File]f6publishing.blob.core.windows.net
https://info.5y1.org/fibroscan-cap-measurement_1_84583a.html
We introduced a novel controlled attenuation parameter (CAP) which was acquired using the FibroScan® equipped with the M probe. This multi-center prospective cohort study was performed in Chinese nonalcoholic fatty liver disease or chronic hepatitis B patients.
[DOCX File]f6publishing.blob.core.windows.net
https://info.5y1.org/fibroscan-cap-measurement_1_429ab8.html
Name of journal: World Journal of Gastroenterology. Manuscript NO: 37399. Manuscript . t. ype: ORIGINAL ARTICLE. Prospective Study. Fatty liver in hepatitis C patients . post-sust
www.researchgate.net
As a result and as compared to other methods, one of the main advantages of CAP was that the quantitative measurement of liver steatosis could be used for analysis.
[DOCX File]Background - Home | Nationwide Service Framework Library
https://info.5y1.org/fibroscan-cap-measurement_1_8527a7.html
A liver stiffness measurement of greater than 12.5 kPA is consistent with cirrhosis and an indication for referral to hospital clinic for secondary care physician and nurse specialist management, including treatment when appropriate, and surveillance for hepatocellular carcinoma (HCC) and varices.
[DOCX File]AusPAR Attachment 2: Extract from the Clinical Evaluation ...
https://info.5y1.org/fibroscan-cap-measurement_1_42ef0a.html
Fibroscan showing cirrhosis or results > 12.5 kPa. FibroTest score of > 0.75 AND anAPRI of > 2 during Screening. ... A 40% cap for cirrhotics included. Amendment 4 key changes; Addition of Part C to the protocol, including: Cohort 5: This cohort will offer additional IFN free options to previous participants in Study P7977-0523 or GS-US-337 ...
[DOCX File]www.vendorportal.ecms.va.gov
https://info.5y1.org/fibroscan-cap-measurement_1_ce8185.html
PAGE 1 OF. 1. REQUISITION NO. 2. CONTRACT NO. 3. AWARD/EFFECTIVE DATE. 4. ORDER NO. 5. SOLICITATION NUMBER. 6. SOLICITATION ISSUE DATE. a. NAME. b. TELEPHONE NO. (No ...
[DOC File]Supplementary references
https://info.5y1.org/fibroscan-cap-measurement_1_0f6529.html
S13. Myers, R. P. et al. Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology. 55, 199–208 (2012). S14. Wong, V. W. et al. Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease. Am. J. Gastroenterol. 107, 1862–1871 ...
Nearby & related entries:
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.